Cargando…
Delays in surgery for cholesteatoma due to COVID-19: is there an impact on rates of recidivism and major complications?
PURPOSE: To evaluate the relationship between the waiting time for surgery, and cholesteatoma recidivism rates and major complications. The secondary aims were to identify any other prognostic factors for cholesteatoma recidivism. METHODS: A retrospective single-centre study of 312 patients who unde...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547560/ https://www.ncbi.nlm.nih.gov/pubmed/33040233 http://dx.doi.org/10.1007/s00405-020-06416-7 |
_version_ | 1783592445618946048 |
---|---|
author | Hussain, Mohammed Hassan Mair, Manish Mahmood, Sara Sakagiannis, Georgios Rojoa, Djamila M. Raheman, Firas J. Irvine, Esmee Rea, Peter |
author_facet | Hussain, Mohammed Hassan Mair, Manish Mahmood, Sara Sakagiannis, Georgios Rojoa, Djamila M. Raheman, Firas J. Irvine, Esmee Rea, Peter |
author_sort | Hussain, Mohammed Hassan |
collection | PubMed |
description | PURPOSE: To evaluate the relationship between the waiting time for surgery, and cholesteatoma recidivism rates and major complications. The secondary aims were to identify any other prognostic factors for cholesteatoma recidivism. METHODS: A retrospective single-centre study of 312 patients who underwent cholesteatoma surgery under the care of a single-surgeon, between 2004 and 2018, was performed. Waiting times for surgery were categorised into ≤ 90 days, 91–180 days, 181–270 days and > 271 days. The outcome measures were cholesteatoma recidivism and major complications (facial nerve palsy or intracranial complications). RESULTS: The mean age was 36.1 years ± 21.5 with 242 adults (77.6%) and 70 children (22.4%). The mean waiting time for surgery was 126.2 days (4.1 months) ± 96.0 days and the overall rate of recidivism was 11.2% (35/312 patients). No instances of facial nerve palsy or intracranial complications were identified. Rates of recidivism by waiting time for surgery were: 15.3% for 118 patients who waited ≤ 90 days, 9.7% for 134 patients who waited 91–180 days, 6.7% for 30 patients who waited 181–270 days and 4.3% for 23 patients who waited > 271 days. There was no significant difference amongst the different waiting time groups for rates of recidivism (p = 0.266). CONCLUSION: Increased waiting times for cholesteatoma surgery do not appear to be associated with increased rates of recidivism or major complications. Clinical judgement will always be required for complicated disease or patients with additional risk factors. The other prognostic factors for recidivism identified in this study were age (< 15 years) and congenital cholesteatoma. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00405-020-06416-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7547560 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-75475602020-10-14 Delays in surgery for cholesteatoma due to COVID-19: is there an impact on rates of recidivism and major complications? Hussain, Mohammed Hassan Mair, Manish Mahmood, Sara Sakagiannis, Georgios Rojoa, Djamila M. Raheman, Firas J. Irvine, Esmee Rea, Peter Eur Arch Otorhinolaryngol Otology PURPOSE: To evaluate the relationship between the waiting time for surgery, and cholesteatoma recidivism rates and major complications. The secondary aims were to identify any other prognostic factors for cholesteatoma recidivism. METHODS: A retrospective single-centre study of 312 patients who underwent cholesteatoma surgery under the care of a single-surgeon, between 2004 and 2018, was performed. Waiting times for surgery were categorised into ≤ 90 days, 91–180 days, 181–270 days and > 271 days. The outcome measures were cholesteatoma recidivism and major complications (facial nerve palsy or intracranial complications). RESULTS: The mean age was 36.1 years ± 21.5 with 242 adults (77.6%) and 70 children (22.4%). The mean waiting time for surgery was 126.2 days (4.1 months) ± 96.0 days and the overall rate of recidivism was 11.2% (35/312 patients). No instances of facial nerve palsy or intracranial complications were identified. Rates of recidivism by waiting time for surgery were: 15.3% for 118 patients who waited ≤ 90 days, 9.7% for 134 patients who waited 91–180 days, 6.7% for 30 patients who waited 181–270 days and 4.3% for 23 patients who waited > 271 days. There was no significant difference amongst the different waiting time groups for rates of recidivism (p = 0.266). CONCLUSION: Increased waiting times for cholesteatoma surgery do not appear to be associated with increased rates of recidivism or major complications. Clinical judgement will always be required for complicated disease or patients with additional risk factors. The other prognostic factors for recidivism identified in this study were age (< 15 years) and congenital cholesteatoma. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00405-020-06416-7) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-10-10 2021 /pmc/articles/PMC7547560/ /pubmed/33040233 http://dx.doi.org/10.1007/s00405-020-06416-7 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Otology Hussain, Mohammed Hassan Mair, Manish Mahmood, Sara Sakagiannis, Georgios Rojoa, Djamila M. Raheman, Firas J. Irvine, Esmee Rea, Peter Delays in surgery for cholesteatoma due to COVID-19: is there an impact on rates of recidivism and major complications? |
title | Delays in surgery for cholesteatoma due to COVID-19: is there an impact on rates of recidivism and major complications? |
title_full | Delays in surgery for cholesteatoma due to COVID-19: is there an impact on rates of recidivism and major complications? |
title_fullStr | Delays in surgery for cholesteatoma due to COVID-19: is there an impact on rates of recidivism and major complications? |
title_full_unstemmed | Delays in surgery for cholesteatoma due to COVID-19: is there an impact on rates of recidivism and major complications? |
title_short | Delays in surgery for cholesteatoma due to COVID-19: is there an impact on rates of recidivism and major complications? |
title_sort | delays in surgery for cholesteatoma due to covid-19: is there an impact on rates of recidivism and major complications? |
topic | Otology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547560/ https://www.ncbi.nlm.nih.gov/pubmed/33040233 http://dx.doi.org/10.1007/s00405-020-06416-7 |
work_keys_str_mv | AT hussainmohammedhassan delaysinsurgeryforcholesteatomaduetocovid19isthereanimpactonratesofrecidivismandmajorcomplications AT mairmanish delaysinsurgeryforcholesteatomaduetocovid19isthereanimpactonratesofrecidivismandmajorcomplications AT mahmoodsara delaysinsurgeryforcholesteatomaduetocovid19isthereanimpactonratesofrecidivismandmajorcomplications AT sakagiannisgeorgios delaysinsurgeryforcholesteatomaduetocovid19isthereanimpactonratesofrecidivismandmajorcomplications AT rojoadjamilam delaysinsurgeryforcholesteatomaduetocovid19isthereanimpactonratesofrecidivismandmajorcomplications AT rahemanfirasj delaysinsurgeryforcholesteatomaduetocovid19isthereanimpactonratesofrecidivismandmajorcomplications AT irvineesmee delaysinsurgeryforcholesteatomaduetocovid19isthereanimpactonratesofrecidivismandmajorcomplications AT reapeter delaysinsurgeryforcholesteatomaduetocovid19isthereanimpactonratesofrecidivismandmajorcomplications |